Merck debuts new genetic stability process to accelerate biopharmaceutical testing

Merck, a leading global technology company with a U.S. laboratory in Rockville, launched the Aptegra CHO Genetic Stability Assay, which leverages whole-genome sequencing and bioinformatics to significantly accelerate customers’ biopharmaceutical safety testing, thereby helping to accelerate customers’ entry into commercial production.